Sharon K Greene

Summary

Affiliation: Harvard Medical School and Harvard Pilgrim Health Care
Country: USA

Publications

  1. doi Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215 3920, USA
    Pharmacoepidemiol Drug Saf 22:335-44. 2013
  2. doi Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215 3920, USA
    Influenza Other Respi Viruses 6:e143-51. 2012
  3. doi Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 175:1100-9. 2012
  4. pmc Gastrointestinal disease outbreak detection using multiple data streams from electronic medical records
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215 3920, USA
    Foodborne Pathog Dis 9:431-41. 2012
  5. doi Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215 3920, USA
    Am J Prev Med 37:552-5. 2009
  6. doi Near real-time vaccine safety surveillance with partially accrued data
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 20:583-90. 2011
  7. pmc Timely detection of localized excess influenza activity in Northern California across patient care, prescription, and laboratory data
    Sharon K Greene
    Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Stat Med 30:549-59. 2011
  8. pmc Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, 133 Brookline Avenue, Boston, MA 02215 3920, USA
    Am J Epidemiol 171:177-88. 2010
  9. doi H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    Grace M Lee
    Center for Child Health Care Studies, Department of Population Medicine, Children s Hospital Boston, Boston, Massachusetts, USA
    Am J Prev Med 41:121-8. 2011
  10. doi Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011
    Alison Tse
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States
    Vaccine 30:2024-31. 2012

Detail Information

Publications11

  1. doi Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215 3920, USA
    Pharmacoepidemiol Drug Saf 22:335-44. 2013
    ..We assessed oseltamivir safety before and during the pandemic using biologically plausible risk intervals, particularly focusing on psychiatric events...
  2. doi Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215 3920, USA
    Influenza Other Respi Viruses 6:e143-51. 2012
    ..Little information is available on clinician adherence to these recommendations. We characterized population-based outpatient antiviral medication usage, including diagnosis and testing practices, before and during the pandemic...
  3. doi Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 175:1100-9. 2012
    ..1 cases per million doses, 95% confidence interval: -3.1, 5.4). Further evaluation to assess GBS risk following both vaccination and respiratory infection is warranted...
  4. pmc Gastrointestinal disease outbreak detection using multiple data streams from electronic medical records
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215 3920, USA
    Foodborne Pathog Dis 9:431-41. 2012
    ..This study's primary objective was to identify data streams from EMRs that may perform well for GI outbreak detection...
  5. doi Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215 3920, USA
    Am J Prev Med 37:552-5. 2009
    ..Studies of influenza vaccination using electronic medical records rely on accurate classification of vaccination status. Vaccinations not entered into electronic records would be unavailable for study...
  6. doi Near real-time vaccine safety surveillance with partially accrued data
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 20:583-90. 2011
    ..We describe practical solutions to these challenges, which were adopted by the VSD Project during pandemic and seasonal influenza vaccine safety surveillance in 2009/2010...
  7. pmc Timely detection of localized excess influenza activity in Northern California across patient care, prescription, and laboratory data
    Sharon K Greene
    Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Stat Med 30:549-59. 2011
    ..Although limited to one health plan, location, and year, these results can inform the choice of data streams for public health surveillance of influenza...
  8. pmc Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, 133 Brookline Avenue, Boston, MA 02215 3920, USA
    Am J Epidemiol 171:177-88. 2010
    ..Near real-time surveillance for selected adverse events can be implemented prospectively to rapidly assess seasonal and pandemic influenza vaccine safety...
  9. doi H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    Grace M Lee
    Center for Child Health Care Studies, Department of Population Medicine, Children s Hospital Boston, Boston, Massachusetts, USA
    Am J Prev Med 41:121-8. 2011
    ..A robust influenza immunization program in the U.S. requires ongoing monitoring of potential adverse events associated with vaccination...
  10. doi Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011
    Alison Tse
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States
    Vaccine 30:2024-31. 2012
    ..Because of the importance of preventing influenza and pneumococcal infections and associated complications, our findings should be placed in a benefit-risk framework to ensure that population health benefits are maximized...
  11. pmc Trends in antibiotic use in Massachusetts children, 2000-2009
    Sharon K Greene
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215 3920, USA
    Pediatrics 130:15-22. 2012
    ..Antibiotic use rates have declined dramatically since the 1990s. We aimed to determine if, when, and at what level the decline in antibiotic-dispensing rates ended and which diagnoses contributed to the trends...